Evidence map›Paper›PMID 42488484›Full record

ArticleAmerican journal of cardiovascular disease2026

Association of reperfusion delay with inflammatory markers and coronary flow impairment assessed by corrected TIMI frame count in STEMI patients undergoing primary PCI: a cohort study.

Reza Arian Nia, Morteza Safi, Mohammad Saeed Soleimani Meigoli, Mohammad Hasan Namazi, Vajihe Kooshamoghadam, Kiarash Fadaeihaghi, Sepita Taghipour, Parsa Mostaghimi Motlagh, Zahra Sadat Shayegh, Shayan Ghanouni and 8 more

Abstract read
In one paragraph

Article in American journal of cardiovascular disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Reza Arian NiaCardiovascular Research Center, Modarres Hospital, Shahid Beheshti University of Medical Sciences Tehran, Iran.
Morteza SafiCardiovascular Research Center, Modarres Hospital, Shahid Beheshti University of Medical Sciences Tehran, Iran.
Mohammad Saeed Soleimani MeigoliNoncommunicable Diseases Research Center, Fasa University of Medical Sciences Fasa, Iran.
Mohammad Hasan NamaziCardiovascular Research Center, Modarres Hospital, Shahid Beheshti University of Medical Sciences Tehran, Iran.
Vajihe KooshamoghadamYazd Cardiovascular Research Center, Non-Communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences Yazd, Iran.
Kiarash FadaeihaghiThe Universal Scientific Education and Research Network (USERN) Denmark.
Sepita TaghipourSchool of Medicine, Tabriz University of Medical Sciences Tabriz, Iran.
Parsa Mostaghimi MotlaghSchool of Medicine, Tabriz University of Medical Sciences Tabriz, Iran.
Zahra Sadat ShayeghSchool of Medicine, Islamic Azad University of Medical Sciences Tehran, Iran.
Shayan GhanouniScool of Medicine, Isfahan University of Medical Sciences Isfahan, Iran.
Mahan SafariSchool of Medicine, Urmia University of Medical Sciences Urmia, Iran.
Aida AzhdarimoghaddamSchool of Medicine, Zahedan University of Medical Sciences Zahedan, Iran.
Mahsa BahmanpourSchool of Pharmacy, Alborz University of Medical Sciences Alborz, Iran.
Farbod KhosraviShahid Beheshti University of Medical Sciences Tehran, Iran.
Nadia PourmohammadiSchool of Medicine, Shahroud University of Medical Sciences Shahroud, Iran.
Sepehr RamezanipourStudent Research Committee, Fasa University of Medical Sciences Fasa, Iran.
Sepehr Mahmoodi AzarStudent Research Committee, Tabriz University of Medical Sciences Tabriz, Iran.
Kamyar KhorsandAtherosclerosis Research Center, Ahvaz Jundishapur University of Medical Sciences Ahvaz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTimely reperfusion remains central to the management of ST-segment elevation myocardial infarction (STEMI). In addition to limiting infarct size, delays in reperfusion may intensify systemic inflammation and contribute to impaired coronary microvascular flow, even when epicardial recanalization appears angiographically successful. This study examined whether reperfusion delay is associated with inflammatory markers at admission and impaired coronary flow measured by corrected TIMI frame count (CTFC) in patients with STEMI treated with primary PCI.

methodsWe conducted a single-center observational cohort study including 104 consecutive patients with STEMI who underwent primary percutaneous coronary intervention (PPCI).Reperfusion delay was defined as symptom-to-balloon time and was grouped into four categories (< 2, 2-4, 4-6, and > 6 hours). Inflammatory markers, including erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), were measured at admission and after PPCI. Coronary flow was quantitatively assessed using the corrected TIMI frame count (CTFC). Associations between reperfusion delay, inflammatory markers, and CTFC were evaluated.

resultsCTFC values increased progressively with longer reperfusion delay, indicating worsening coronary flow (P < 0.05). Admission ESR increased significantly with longer symptom-to-balloon time (P < 0.05), and higher CRP categories were more frequently observed among patients with delayed reperfusion (P < 0.05). Higher ESR and CRP levels at admission were also associated with increased CTFC values. Post-procedural ESR and CRP levels, however, showed no significant association with reperfusion delay or CTFC (P > 0.05). Higher ESR and CRP levels at admission were also linked with increased CTFC values. Post-procedural ESR and CRP levels, however, showed no significant association with reperfusion delay or CTFC.

conclusionsIn patients with STEMI undergoing primary PCI, delayed reperfusion is associated with increased inflammatory burden at presentation and impaired coronary flow as assessed by corrected TIMI frame count. Taken together, these findings suggest that inflammatory activation during prolonged ischemia may contribute to impaired coronary flow and highlight the continued importance of minimizing reperfusion delay.

Indexed as

corrected TIMI frame countinflammationprimary percutaneous coronary interventionreperfusion delayST-segment elevation myocardial infarction

Identifiers

PMID42488484
PMCPMC13389452

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.